Abstract:INTRODUCTION: White adipose tissue is the main source of circulating Asprosin - a newly identified protein hormone encoded by FBN1. It triggers hepatic glucose release into the bloodstream in order to maintain hemal energy standards between meals and is suggested to serve as target battling obesity and T2D. In obese male individuals plasma Asprosin levels were found to be increased twofold and in male Ob/Ob-mice, the Fbn1-mRNA expression was also elevated in skeletal muscle compared to non-obese animals (Romero et al. Cell 2016). PURPOSE: (i) To estimate the basal Asprosin secretion in obese women and (ii) to analyze the changes in Asprosin response after an acute bout of high intensity exercise in obese versus non-obese subjects. METHODS: 12 highly obese women (age 47.1±14.2; BMI 47.3±12.7) and 6 men (age 53.7±7.5; BMI 46.3±12.0) were matched to age and sex adjusted controls (age 46.1±13.6; BMI 21.6±2.2, age 52.3±5.0; BMI 23.8±1.5) and their resting serum Asprosin levels were analyzed using the human Asprosin ELISA kit from Wuhan EIAab Science, PR China. To evaluate Asprosin response to an exhaustive bout of exercise 14 obese individuals (10 women and 4 men) underwent an adapted treadmill protocol at individually adjusted speeds between 2 and 4.9 km/h constantly with increasing slopes, finishing >85% of their age-dependent maximal HR. Normal weight recreational athletes, 8 females (age 26.4±5.4; La max 9.0±1.8; HR max 190.6±8.6) and 9 males (age 25.8±6.8; La max 7.3±2.8; HR max 193.0±12.3) serving as controls performed a treadmill running test at a starting speed of 6 km/h with 2 km/h increments every 3 min accompanied by venous blood draws pre- and immediately post exercise. RESULTS: Resting Asprosin levels among obese women and men were comparable (19.9±36.7 and 7.1±7.5) and also similar to non-obese subjects (9.2±9.5 and 12.4±10.4) yet with huge individual variations. These results were reflected when individuals experienced acute exhaustive exercise with high interindividual distributions but low intraindividual spreadings applying to obese and lean subjects. CONCLUSIONS: Contrary to findings of Romero et al. we could not reproduce differences in Asprosin levels between obese and non-obese subjects. Also an acute bout of treadmill exercise did not affect Asprosin secretion in order to refuel hemal glucose status.

Protein tyrosine phosphatase receptor δ serves as the orexigenic asprosin receptor

OLFR734 Mediates Glucose Metabolism as a Receptor of Asprosin.

Asprosin is a Centrally Acting Orexigenic Hormone

Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects

Asprosin, A Newly Identified Fasting-Induced Hormone Is Not Elevated In Obesity And Is Insensitive To Acute Exercise: 3592 Board #39 June 3 8

Asprosin-neutralizing antibodies as a treatment for metabolic syndrome

In Silico and In Vitro Mapping of Receptor-Type Protein Tyrosine Phosphatase Receptor Type D in Health and Disease: Implications for Asprosin Signalling in Endometrial Cancer and Neuroblastoma

Asprosin, a C-Terminal Cleavage Product of Fibrillin 1 Encoded by the FBN1 Gene, in Health and Disease

Novel adipokine asprosin modulates browning and adipogenesis in white adipose tissue

A brown fat-enriched adipokine, ASRA, is a leptin receptor antagonist that stimulates appetite

Asprosin: its function as a novel endocrine factor in metabolic-related diseases

Asprosin: A Novel Player in Metabolic Diseases

Elevated Circulating Asprosin Impedes Low Intensity Exercise-induced Weight Loss In Obese Individuals: 3893 Board #210 May 30 9:00 AM - 10:30 AM

Oxygen-Dependent Aspects of Asprosin Action

Db121039 1876..1887

Opioidergic Regulation of AgRP Neurons

A Novel Nociceptin Receptor Antagonist LY2940094 Inhibits Excessive Feeding Behavior in Rodents: A Possible Mechanism for the Treatment of Binge Eating Disorder

Enhanced purinergic signaling in the paraventricular hypothalamus induces hyperphagic obesity and insulin resistance

Asprosin contributes to pathogenesis of obesity by adipocyte mitophagy induction to inhibit white adipose browning in mice

Pxr Ablation Alleviates Diet-Induced and Genetic Obesity and Insulin Resistance in Mice

Asperuloside Enhances Taste Perception and Prevents Weight Gain in High-Fat Fed Mice